Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 41401-41450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06627998
Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer
N/ARecruiting
82 participants
Started: Apr 12, 2023 · Completed: Dec 31, 2024
3 conditions2 sponsors1 location
NCT05717387
Intermittent Eating on Glucose Homeostasis in Prediabetes
NARecruiting
87 participants
Started: Apr 11, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05756491
Outpatient Hospitalization of Unaccompanied Patients at Home for Endovascular Treatment of Peripheral Arterial Disease.
NARecruiting
2,000 participants
Started: Apr 11, 2023 · Completed: Apr 11, 2026
1 condition1 sponsor20 locations
NCT06318598
Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis
N/ARecruiting
200 participants
Started: Apr 11, 2023 · Completed: Apr 10, 2026
2 conditions3 sponsors3 locations
NCT05676944
Vestibular Implantation in Older Adults
NARecruiting
15 participants
Started: Apr 11, 2023 · Completed: Jan 31, 2028
10 conditions3 sponsors1 location
NCT05421325
Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults
PHASE2Recruiting
72 participants
Started: Apr 11, 2023 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05816369
Oral Nutritional Supplement Preferences in Patients With Cancer
NARecruiting
50 participants
Started: Apr 11, 2023 · Completed: Sep 30, 2024
2 conditions3 sponsors1 location
NCT06009627
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
PHASE2/PHASE3Recruiting
119 participants
Started: Apr 11, 2023 · Completed: Sep 11, 2026
1 condition1 sponsor1 location
NCT05851378
Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
EARLY_PHASE1Recruiting
40 participants
Started: Apr 11, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT05632627
Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial
PHASE2Recruiting
120 participants
Started: Apr 11, 2023 · Completed: Dec 15, 2025
1 condition2 sponsors1 location
NCT06053320
Spatial-Motor Stroke-Rehab Study
NARecruiting
65 participants
Started: Apr 11, 2023 · Completed: Mar 31, 2026
2 conditions2 sponsors3 locations
NCT05782270
Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy
PHASE4Recruiting
202 participants
Started: Apr 11, 2023 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05997810
Parathyroid Tumor Clonal Status
N/ARecruiting
839 participants
Started: Apr 11, 2023 · Completed: Jan 31, 2027
2 conditions1 sponsor3 locations
NCT05555589
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
PHASE3Recruiting
70 participants
Started: Apr 11, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor32 locations
NCT05590455
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
PHASE2Recruiting
130 participants
Started: Apr 11, 2023 · Completed: Jun 30, 2027
2 conditions1 sponsor3 locations
NCT06786000
Neurophysiological and Behavioral Effects of Combining Transcranial Direct Current Stimulation (tDCS) and Modified-Constraint Induced Movement Therapy (mCIMT)
NARecruiting
300 participants
Started: Apr 11, 2023 · Completed: Apr 11, 2025
3 conditions3 sponsors1 location
NCT05363826
Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®
PHASE1Recruiting
30 participants
Started: Apr 11, 2023 · Completed: May 31, 2026
2 conditions3 sponsors1 location
NCT05801978
Durability of Vaccine Responses
PHASE4Recruiting
66 participants
Started: Apr 11, 2023 · Completed: Sep 30, 2026
1 condition3 sponsors3 locations
NCT05835817
Magnetoencephalography by Optical Pumping Magnetometer
NARecruiting
70 participants
Started: Apr 11, 2023 · Completed: Apr 30, 2026
4 conditions1 sponsor1 location
NCT05995548
Mechanisms Involved in the Developement of Sports Addiction Among Military Personnel
N/ARecruiting
20 participants
Started: Apr 11, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05421715
Remote Digital Care Effects in Adolescents With Type 1 Diabetes
NARecruiting
30 participants
Started: Apr 11, 2023 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT05336851
Emergency PWAS in Respiratory Infectious Disease
N/ARecruiting
2,000 participants
Started: Apr 11, 2023 · Completed: May 1, 2025
8 conditions1 sponsor1 location
NCT05607719
Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD
PHASE2Recruiting
30 participants
Started: Apr 11, 2023 · Completed: Mar 30, 2026
1 condition2 sponsors1 location
NCT05574634
The Role of the Locus Coeruleus in Age-related Distractibility
NARecruiting
200 participants
Started: Apr 11, 2023 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT05750992
Ultrasound Guided TAPB vs Surgical TAPB With Bupivacaine in Cesarean Section
NARecruiting
50 participants
Started: Apr 10, 2023 · Completed: Nov 30, 2024
5 conditions1 sponsor1 location
NCT05777343
Exercise, PNE and Cognitive Training in Individuals With Chronic Low Back Pain
NARecruiting
83 participants
Started: Apr 10, 2023 · Completed: Mar 1, 2024
1 condition3 sponsors1 location
NCT05654922
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
PHASE3Recruiting
100 participants
Started: Apr 10, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor16 locations
NCT05841732
MyBack - A Behavior Change Informed Exercise Program to Prevent Low Back Pain Recurrences
NARecruiting
186 participants
Started: Apr 10, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05584124
rTMS for Post-stroke Fatigue
NARecruiting
60 participants
Started: Apr 10, 2023 · Completed: Oct 29, 2027
3 conditions2 sponsors1 location
NCT05854823
The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR
NARecruiting
23 participants
Started: Apr 10, 2023 · Completed: Apr 9, 2027
1 condition1 sponsor1 location
NCT06447311
Assessing the Clinical Efficacy of Hyaluronic Acid Hydrogel in Papilla Augmentation: A Clinical Study.
NARecruiting
24 participants
Started: Apr 10, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05825443
Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients
PHASE2Recruiting
57 participants
Started: Apr 10, 2023 · Completed: Apr 1, 2029
2 conditions2 sponsors1 location
NCT05286788
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
PHASE2Recruiting
38 participants
Started: Apr 10, 2023 · Completed: Apr 10, 2027
2 conditions2 sponsors10 locations
NCT05807568
MIStreatment Screening in Elders Before Discharge
NARecruiting
100 participants
Started: Apr 10, 2023 · Completed: Jun 30, 2026
7 conditions1 sponsor1 location
NCT05726786
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
PHASE3Recruiting
232 participants
Started: Apr 10, 2023 · Completed: Oct 31, 2026
7 conditions3 sponsors3 locations
NCT05753020
A Pilot Study of The CKM JumpStart Tool
NARecruiting
76 participants
Started: Apr 10, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05544019
Study of SGR-1505 in Mature B-Cell Neoplasms
PHASE1Recruiting
52 participants
Started: Apr 10, 2023 · Completed: Mar 31, 2026
26 conditions1 sponsor36 locations
NCT05953519
Meeting an Unmet Need in Multiple Sclerosis
NARecruiting
24 participants
Started: Apr 10, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05551793
Regeneron AA Multicenter (Dupilumab)
PHASE2Recruiting
68 participants
Started: Apr 10, 2023 · Completed: Nov 3, 2027
1 condition2 sponsors3 locations
NCT05785741
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
1,000 participants
Started: Apr 10, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor21 locations
NCT05669976
Suicide Prevention for Sexual and Gender Minority Youth (Randomized Controlled Trial)
NARecruiting
170 participants
Started: Apr 10, 2023 · Completed: Oct 15, 2026
1 condition2 sponsors1 location
NCT05863442
Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants
PHASE1Recruiting
120 participants
Started: Apr 10, 2023 · Completed: Oct 5, 2024
1 condition1 sponsor1 location
NCT06218433
Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)
NARecruiting
200 participants
Started: Apr 10, 2023 · Completed: Dec 31, 2034
2 conditions2 sponsors2 locations
NCT05791305
Double Duty Interventions and Its Impact on Double Burden of Malnutrition in Children Under Five Years
NARecruiting
456 participants
Started: Apr 10, 2023 · Completed: Dec 30, 2025
5 conditions1 sponsor2 locations
NCT05851456
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
EARLY_PHASE1Recruiting
20 participants
Started: Apr 10, 2023 · Completed: Apr 30, 2026
4 conditions2 sponsors1 location
NCT05852119
Prospective Study for the Outpatient Treatment of Patients With Very Low Risk Acute Symptomatic Pulmonary Embolism.
NARecruiting
300 participants
Started: Apr 10, 2023 · Completed: Feb 28, 2026
2 conditions1 sponsor10 locations
NCT06274736
Safety and Performance of Motiva® Sizers
N/ARecruiting
330 participants
Started: Apr 10, 2023 · Completed: Jul 10, 2027
5 conditions1 sponsor1 location
NCT05817279
AI-aided Optical Coherence Tomography for the Detection of Basal Cell Carcinoma
N/ARecruiting
124 participants
Started: Apr 10, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06102746
Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma
N/ARecruiting
20 participants
Started: Apr 10, 2023 · Completed: Apr 10, 2026
1 condition1 sponsor1 location
NCT05640271
Tocilizumab for Acute Chest Syndrome
PHASE2Recruiting
200 participants
Started: Apr 10, 2023 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location